Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Hadaschik

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Der Urologe. Ausg. A|May 10, 2018
[Paradigm shift in urology : Prostate cancer diagnosis using MRI-targeted or standard transrectal ultrasonography-guided biopsy]B Hadaschik
Der Urologe. Ausg. A|May 24, 2018
[New treatment option-apalutamide for nonmetastatic, castration-resistant prostate cancer]B Hadaschik, A Panic
Der Urologe. Ausg. A|June 3, 2021
[Elective radiotherapy of pelvic lymph nodes in high-risk prostate cancer? : Evaluation of the relationship between the relative risk reduction of PSA (prostate-specific antigen) relapse within 5 years and absolute survival benefit]M Stuschke, B Hadaschik
Der Urologe. Ausg. A|May 11, 2019
[Management of localized prostate cancer]B Hadaschik, C G Stief
Der Urologe. Ausg. A|April 24, 2020
[Minimally invasive surgery for aggressive tumors]C-H Ohlmann, B Hadaschik
Urologie (Heidelberg, Germany)|March 31, 2022
[Combination hormone therapy for non-metastatic prostate cancer]Carsten Ohlmann, V Grünwald, B Hadaschik
World Journal of Urology|November 7, 2019
M0CRPC overview of management optionsY Hess-Busch, B Hadaschik, J Hess
Der Urologe. Ausg. A|April 11, 2020
[Treatment concepts for primary oligometastatic prostate cancer]S Knipper, M Graefen, B Hadaschik, et al.
Der Urologe. Ausg. A|November 26, 2021
[Treatment of primary oligometastatic prostate cancer]S Scharl, B Hadaschik, T Wiegel, et al.
Der Urologe. Ausg. A|March 7, 2019
[Fusion biopsies for primary diagnosis of prostate cancer : Implementation, benefits, and clinical aspects]L Püllen, B Hadaschik, D Eberli, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Der Urologe. Ausg. A|May 10, 2018
[Paradigm shift in urology : Prostate cancer diagnosis using MRI-targeted or standard transrectal ultrasonography-guided biopsy]B Hadaschik
Der Urologe. Ausg. A|May 24, 2018
[New treatment option-apalutamide for nonmetastatic, castration-resistant prostate cancer]B Hadaschik, A Panic
Der Urologe. Ausg. A|June 3, 2021
[Elective radiotherapy of pelvic lymph nodes in high-risk prostate cancer? : Evaluation of the relationship between the relative risk reduction of PSA (prostate-specific antigen) relapse within 5 years and absolute survival benefit]M Stuschke, B Hadaschik
Der Urologe. Ausg. A|May 11, 2019
[Management of localized prostate cancer]B Hadaschik, C G Stief
Der Urologe. Ausg. A|April 24, 2020
[Minimally invasive surgery for aggressive tumors]C-H Ohlmann, B Hadaschik
Urologie (Heidelberg, Germany)|March 31, 2022
[Combination hormone therapy for non-metastatic prostate cancer]Carsten Ohlmann, V Grünwald, B Hadaschik
World Journal of Urology|November 7, 2019
M0CRPC overview of management optionsY Hess-Busch, B Hadaschik, J Hess
Der Urologe. Ausg. A|April 11, 2020
[Treatment concepts for primary oligometastatic prostate cancer]S Knipper, M Graefen, B Hadaschik, et al.
Der Urologe. Ausg. A|November 26, 2021
[Treatment of primary oligometastatic prostate cancer]S Scharl, B Hadaschik, T Wiegel, et al.
Der Urologe. Ausg. A|March 7, 2019
[Fusion biopsies for primary diagnosis of prostate cancer : Implementation, benefits, and clinical aspects]L Püllen, B Hadaschik, D Eberli, et al.
Pageof 5